American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

ABBVIE INC.

ABBV Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

ABBV historical prices

$ABBV stock is featured in our Rob Bresnahan, Tom Carper, and Dan Meuser strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of ABBV by members of U.S. Congress

Politician Type Traded
Pete Sessions House / R Sale $15,001 - $50,000 Sep 14, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 02, 2026
Ro Khanna House / D Purchase $15,001 - $50,000 May 15, 2026
Josh Gottheimer House / D Sale $1,001 - $15,000 May 05, 2026
Ro Khanna House / D Purchase $15,001 - $50,000 May 01, 2026
Ro Khanna House / D Sale $15,001 - $50,000 Apr 13, 2026
Ro Khanna House / D Sale $15,001 - $50,000 Mar 30, 2026
Alan Armstrong Senate / R Purchase $15,001 - $50,000 Mar 27, 2026
Ro Khanna House / D Purchase $15,001 - $50,000 Feb 05, 2026
Ro Khanna House / D Sale $15,001 - $50,000 Jan 29, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 23, 2026
Julie Johnson House / D Sale $1,001 - $15,000 Dec 18, 2025
Julia Letlow House / R Sale $1,001 - $15,000 Dec 08, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Nov 13, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 31, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 30, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Oct 30, 2025
John Boozman Senate / R Sale (Partial) $1,001 - $15,000 Aug 22, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Aug 14, 2025
John Boozman Senate / R Sale (Partial) $1,001 - $15,000 Aug 11, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jul 22, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Jul 22, 2025
Ritchie Torres House / D Sale $1,001 - $15,000 Jul 11, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 01, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 01, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jun 17, 2025
Ro Khanna House / D Purchase $15,001 - $50,000 May 28, 2025
Josh Gottheimer House / D Purchase $1,001 - $15,000 May 22, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 May 15, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 May 05, 2025
Julia Letlow House / R Purchase $1,001 - $15,000 Apr 28, 2025
Josh Gottheimer House / D Sale $1,001 - $15,000 Apr 17, 2025
Jefferson Shreve House / R Sale $50,001 - $100,000 Apr 17, 2025
Ro Khanna House / D Sale $15,001 - $50,000 Apr 09, 2025
Robert Bresnahan House / R Sale $1,001 - $15,000 Apr 08, 2025
Jared Moskowitz House / D Purchase $1,001 - $15,000 Apr 07, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 04, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 04, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 04, 2025
Josh Gottheimer House / D Purchase $1,001 - $15,000 Apr 03, 2025
Dwight Evans House / D Sale $1,001 - $15,000 Apr 03, 2025
Josh Gottheimer House / D Purchase $1,001 - $15,000 Apr 01, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Mar 17, 2025
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 06, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 Feb 25, 2025
Jefferson Shreve House / R Purchase $50,001 - $100,000 Feb 24, 2025
ABBV Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ABBV Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ABBV Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in ABBV holdings by institutional investors

Insider Trading

Quarterly net insider trading by ABBV's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $1,160,000 Jul 20, 2026 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Trade (domestic/foreign)
  • $2,080,000 Apr 20, 2026 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Trade (domestic/foreign)
  • $1,330,000 Jan 20, 2026 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Trade (domestic/foreign)
  • $980,000 Oct 20, 2025 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace
  • $1,160,000 Jul 21, 2025 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Trade (domestic/foreign)
  • $2,110,000 Apr 21, 2025 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace
  • $1,080,000 Jan 21, 2025 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace
  • $1,280,000 Oct 21, 2024 Issue: Labor Issues/Antitrust/Workplace Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $580,000 Jul 22, 2024 Issue: Labor Issues/Antitrust/Workplace Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $830,000 Jan 22, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $750,000 Oct 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $600,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $970,000 Jan 20, 2023 Issue: Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $2,370,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $880,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $3,980,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $1,290,000 Jan 20, 2022 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $1,940,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $680,000 Jul 20, 2021 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $3,090,000 Apr 20, 2021 Issue: Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Medicare/Medicaid Trade (domestic/foreign)
  • $650,000 Jan 20, 2021 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $1,430,000 Oct 20, 2020 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $670,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $2,980,000 Apr 20, 2020 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $970,000 Jan 21, 2020 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Budget/Appropriations
  • $1,790,000 Oct 21, 2019 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $900,000 Jul 22, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $2,680,000 Apr 22, 2019 Issue: Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues
  • $1,820,000 Jan 22, 2019 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $600,000 Oct 22, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $790,000 Jul 20, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $2,890,000 Apr 20, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $1,280,000 Jan 22, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Disaster Planning/Emergencies
  • $1,200,000 Oct 20, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $720,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Budget/Appropriations
  • $2,460,000 Apr 20, 2017 Issue: Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark
  • $1,040,000 Jan 20, 2017 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $2,610,000 Oct 28, 2016 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Budget/Appropriations
  • $1,920,000 Oct 20, 2016 Issue: Budget/Appropriations Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid
  • $1,700,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Budget/Appropriations
  • $1,180,000 Jan 20, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,240,000 Oct 19, 2015 Issue: Health Issues Taxation/Internal Revenue Code Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark Trade (domestic/foreign)
  • $930,000 Oct 19, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
  • $1,870,000 Oct 19, 2015 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Budget/Appropriations Trade (domestic/foreign)
  • $1,010,000 Jan 20, 2015 Issue: Budget/Appropriations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
  • $1,600,000 Oct 17, 2014 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations Trade (domestic/foreign)
  • $880,000 Jul 21, 2014 Issue: Budget/Appropriations Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Copyright/Patent/Trademark
  • $1,450,000 Apr 21, 2014 Issue: Budget/Appropriations Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $600,000 Jan 21, 2014 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Budget/Appropriations Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $630,000 Oct 21, 2013 Issue: Science/Technology Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Budget/Appropriations Health Issues
  • $1,180,000 Oct 21, 2013 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Budget/Appropriations Medicare/Medicaid
  • $770,000 Apr 22, 2013 Issue: Health Issues Budget/Appropriations Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
Revolving Door

Former government officials who have lobbied for ABBV

81 former government officials from 44 congressional offices at 14 lobbying firms have lobbied for ABBV, most recently Jul 21, 2026.

  • Paul Brathwaite Congress Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, U.S. Department of Labor; Special Assistant to the Secretary, U.S. Department of Labor. Formerly Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, · FEDERAL STREET STRATEGIES, LLC · Jul 21, 2026
  • Andy Levin
    Ven Neralla House New Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff, U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep. Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio; Senior Advisor, USDA; OPP; and MCC. Formerly with Andy Levin · FEDERAL STREET STRATEGIES, LLC · Jul 21, 2026
  • Zoe Lofgren
    Stacey Leavandosky House New Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation Formerly with Zoe Lofgren · FEDERAL STREET STRATEGIES, LLC · Jul 21, 2026
  • Amy Klobuchar
    Kaade Wallace Senate New Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum Formerly with Amy Klobuchar · FEDERAL STREET STRATEGIES, LLC · Jul 21, 2026
  • Raissa Downs Senate Prin. Dep. Asst. Sec for Leg.-HHS; Dep. Asst. Sec. for Leg.-HSS; Staff Dir., Sub Cmte. on Employment, Sen. HELP Cmte. Formerly HELP Cmte. · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Jennifer Young Congress Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance Formerly Cmte. on Finance · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Steny H. Hoyer
    Elizabeth Murray House Senior Policy Advisor, Democratic Whip Steny Hoyer; Leg. Asst., Rep. Mike Thompson, Rep. Bob Matsui, and Sen. Bob Graham Formerly with Steny H. Hoyer · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Jim DeMint
    Charlotte Ivancic Senate Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner Formerly with Jim DeMint · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
See all 81 on the Revolving Door dashboard
Corporate Lobbying

ABBV Estimated quarterly lobbying spending

Revenue Breakdown

ABBV Revenue by Segment or Geography

By Segment
By Geography
ABBV Income Statement
ABBV Balance Sheet
ABBV Cash Flow
U.S. Patents

New ABBV patent grants

  • Patent Title: Container cap Jul. 14, 2026
  • Patent Title: Carrying vest Jul. 08, 2025
  • Patent Title: Infusion pump May. 20, 2025
  • Patent Title: Carrying vest Apr. 15, 2025
  • Patent Title: Container cap Mar. 11, 2025
  • Patent Title: Carrying pack for medical device Mar. 11, 2025
  • Patent Title: Container cap Jul. 09, 2024
  • Patent Title: Carrying pack Dec. 12, 2023
  • Patent Title: Medication packaging combined with dispensing container Mar. 03, 2020
  • Patent Title: Container cap Feb. 25, 2020
  • Patent Title: Medication packaging and dispensing system Feb. 05, 2019
  • Patent Title: Automatic injection device Oct. 30, 2018
  • Patent Title: Medication packaging combined with dispensing container Oct. 23, 2018
  • Patent Title: Medication packaging and dispensing system Jun. 26, 2018
  • Patent Title: Bromodomain inhibitors Jun. 12, 2018
  • Patent Title: Indole and indoline derivatives and methods of use thereof May. 29, 2018
  • Patent Title: Automatic injection device May. 29, 2018
  • Patent Title: Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography May. 22, 2018
  • Patent Title: 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use May. 15, 2018
  • Patent Title: Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-alpla]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrol and solid state forms thereof May. 08, 2018
  • Patent Title: Protein purification methods to reduce acidic species May. 01, 2018
  • Patent Title: Wearable injector device Mar. 13, 2018
  • Patent Title: Wearable injector device Mar. 13, 2018
  • Patent Title: Interface portion of a pump Jan. 16, 2018
  • Patent Title: Medication container Dec. 12, 2017
  • Patent Title: Carrying case for medical delivery device Sep. 05, 2017
  • Patent Title: Carrying case for medical delivery device Aug. 08, 2017
  • Patent Title: Connector holder Jul. 25, 2017
  • Patent Title: Garment with carrying case for medical delivery device Jun. 13, 2017
  • Patent Title: Open tray with riser and guide panels May. 16, 2017
  • Patent Title: Injection tool Apr. 25, 2017
  • Patent Title: Bumper Mar. 07, 2017
  • Patent Title: Connector holder Feb. 28, 2017
  • Patent Title: Delivery device including pump and cassette Jan. 31, 2017
  • Patent Title: Cassette Jan. 31, 2017
  • Patent Title: Interface portion of a cassette Jan. 24, 2017
  • Patent Title: Carrying case for medical delivery device Jan. 17, 2017
  • Patent Title: Delivery device including pump and cassette Sep. 13, 2016
  • Patent Title: Connector Aug. 23, 2016
  • Patent Title: Connector Aug. 23, 2016
  • Patent Title: Garment with carrying case for medical delivery device Aug. 23, 2016
  • Patent Title: Injection tool Jul. 05, 2016
  • Patent Title: Template for a prescription medicine container Feb. 02, 2016
  • Patent Title: Template for a prescription medicine container Jan. 19, 2016
  • Patent Title: Template for a prescription medicine container Jan. 12, 2016
  • Patent Title: Interface portion of a pump Jan. 05, 2016
  • Patent Title: Pump Nov. 24, 2015
  • Patent Title: Template for a prescription medicine container Jun. 16, 2015
  • Patent Title: Template for a prescription medicine container Jun. 16, 2015
  • Patent Title: Template for a prescription medicine container Jun. 09, 2015
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to ABBV from public contracts

ABBV News

Recent insights relating to ABBV

CNBC Recommendations

Recent picks made for ABBV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ABBV

ABBV Analyst Ratings

ABBV Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ABBV Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ABBV stock a Buy, Sell, or Hold?

  • What is the price target for $ABBV stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ABBV Top Shareholders
Shareholder
Shares Held
ABBV Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ABBV stock?

  • Who owns the most shares of $ABBV stock?

  • What funds own $ABBV stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ABBV Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ABBV Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ABBV

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

  • Address North Chicago, IL
  • Market Cap 468.5 billion
  • Employees 57,000
  • Industrial Classification Pharmaceutical Preparations

ABBVIE INC. (ABBV) Historical Stock Prices

ABBVIE INC. (ABBV) closed at $265.12 on September 24, 2026. Over the past year its adjusted close ranged from $195.99 to $265.97. Daily prices go back to January 2, 2014, 3,201 trading days in all.

  • 1 month-0.25%
  • 3 months+9.81%
  • Year to date+18.77%
  • 1 year+24.26%
  • 3 years+90.27%
  • 5 years+197.75%
  • Max+745.38%
See every congressional and insider trade on the ABBV price chart

Quiver Premium charts ABBV's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 265.37 267.41 263.09 265.12 265.12 3,458,166
Sep 23, 2026 266.00 269.39 263.59 265.08 265.08 3,469,242
Sep 22, 2026 263.10 266.82 262.14 265.21 265.21 2,766,286
Sep 21, 2026 263.07 266.60 261.23 264.48 264.48 3,438,150
Sep 18, 2026 263.29 266.34 262.44 263.96 263.96 8,176,607
Sep 17, 2026 262.61 264.62 260.88 264.02 264.02 3,509,941
Sep 16, 2026 261.99 264.00 260.98 262.51 262.51 3,118,268
Sep 15, 2026 260.00 264.81 257.80 263.04 263.04 5,120,219
Sep 14, 2026 261.67 264.65 260.10 261.77 261.77 4,512,420
Sep 11, 2026 253.92 259.61 253.92 257.12 257.12 4,308,856
Sep 10, 2026 251.23 255.31 249.74 255.00 255.00 4,397,653
Sep 9, 2026 247.73 251.18 246.77 250.91 250.91 3,866,951
Sep 8, 2026 251.84 254.62 248.41 248.78 248.78 5,572,102
Sep 4, 2026 257.96 258.91 255.58 256.46 256.46 4,729,800
Sep 3, 2026 264.00 264.25 257.14 260.21 260.21 2,878,739
Sep 2, 2026 262.70 262.97 257.70 261.72 261.72 4,225,524
Sep 1, 2026 260.99 262.26 257.79 259.99 259.99 3,866,739
Aug 31, 2026 254.17 258.24 252.33 256.42 256.42 4,315,487
Aug 28, 2026 258.67 259.00 255.08 255.48 255.48 3,224,862
Aug 27, 2026 260.81 262.50 257.25 258.15 258.15 4,764,797
Aug 26, 2026 264.60 265.00 260.31 262.90 262.90 3,308,871
Aug 25, 2026 264.50 266.90 263.02 265.79 265.79 3,671,623
Aug 24, 2026 263.99 266.04 262.07 264.52 264.52 3,883,803
Aug 21, 2026 260.70 266.84 260.10 264.96 264.96 5,157,192
Aug 20, 2026 265.69 265.93 260.48 261.83 261.83 5,228,907
Aug 19, 2026 261.51 266.96 259.55 265.97 265.97 5,535,972
Aug 18, 2026 253.93 259.18 252.41 258.92 258.92 5,010,229
Aug 17, 2026 249.49 251.49 248.31 250.33 250.33 4,648,771
Aug 14, 2026 250.60 250.61 247.68 249.46 249.46 4,195,386
Aug 13, 2026 252.94 255.29 249.35 250.82 250.82 4,370,406
Aug 12, 2026 245.98 250.09 245.52 248.76 248.76 3,780,452
Aug 11, 2026 248.14 250.76 247.18 250.09 250.09 4,485,470
Aug 10, 2026 245.65 248.01 244.03 247.97 247.97 4,209,941
Aug 7, 2026 243.62 246.76 241.95 246.04 246.04 4,930,711
Aug 6, 2026 249.04 249.95 241.20 243.87 243.87 4,570,167
Aug 5, 2026 247.00 249.38 243.76 246.20 246.20 5,193,732
Aug 4, 2026 246.74 246.91 242.38 243.80 243.80 8,028,831
Aug 3, 2026 251.45 256.20 244.44 245.10 245.10 7,435,935
Jul 31, 2026 252.54 255.52 247.00 250.94 250.94 7,258,176
Jul 30, 2026 258.38 259.89 253.51 257.41 257.41 6,406,625
Jul 29, 2026 264.21 267.47 262.75 263.30 263.30 5,563,736
Jul 28, 2026 262.83 266.92 261.45 263.20 263.20 7,060,442
Jul 27, 2026 259.00 262.10 256.78 256.91 256.91 5,404,809
Jul 24, 2026 258.54 260.22 256.76 259.36 259.36 4,195,437
Jul 23, 2026 253.98 258.38 253.10 256.92 256.92 4,623,010
Jul 22, 2026 257.81 257.81 252.25 253.30 253.30 4,953,191
Jul 21, 2026 253.70 257.06 252.60 256.10 256.10 4,819,291
Jul 20, 2026 253.10 256.15 252.68 253.38 253.38 4,332,803
Jul 17, 2026 257.00 260.96 254.29 254.49 254.49 6,872,705
Jul 16, 2026 244.75 254.54 243.50 254.39 254.39 6,555,488
Jul 15, 2026$1.73 dividend 243.32 247.75 243.07 244.11 244.11 6,388,965
Jul 14, 2026 245.99 246.42 243.19 244.78 243.06 5,247,223
Jul 13, 2026 248.37 249.74 244.61 248.00 246.25 4,156,363
Jul 10, 2026 251.00 251.66 245.05 248.08 246.33 5,780,990
Jul 9, 2026 251.20 254.86 247.99 249.91 248.15 5,526,006
Jul 8, 2026 253.25 255.82 250.70 252.74 250.96 7,578,707
Jul 7, 2026 257.21 260.35 254.27 254.65 252.86 8,238,267
Jul 6, 2026 259.92 260.92 253.60 254.76 252.97 8,580,220
Jul 2, 2026 252.30 261.63 250.51 261.07 259.23 7,114,422
Jul 1, 2026 250.75 251.80 247.56 251.06 249.29 6,987,982
Jun 30, 2026 255.00 255.50 250.10 251.64 249.87 6,999,707
Jun 29, 2026 253.05 255.99 249.20 254.31 252.52 9,760,531
Jun 26, 2026 245.25 253.35 244.66 253.35 251.57 52,635,078
Jun 25, 2026 233.66 244.61 233.66 243.14 241.43 10,281,847
Jun 24, 2026 236.35 237.36 232.85 234.89 233.24 7,311,033
Jun 23, 2026 232.97 235.31 231.30 234.76 233.11 7,366,040
Jun 22, 2026 221.94 232.32 221.94 230.01 228.39 9,912,770
Jun 18, 2026 221.37 222.35 215.37 216.49 214.97 9,646,078
Jun 17, 2026 222.40 222.84 218.83 221.23 219.67 5,624,375
Jun 16, 2026 223.31 223.50 219.15 222.47 220.90 5,945,518
Jun 15, 2026 226.00 226.50 220.00 221.59 220.03 5,261,900
Jun 12, 2026 227.50 228.40 224.32 227.73 226.13 4,086,503
Jun 11, 2026 226.01 227.55 224.04 224.77 223.19 4,569,353
Jun 10, 2026 226.93 227.14 224.12 224.95 223.37 4,147,303
Jun 9, 2026 224.80 227.14 221.72 225.42 223.83 4,257,921
Jun 8, 2026 226.75 228.58 221.16 223.07 221.50 4,915,633
Jun 5, 2026 227.37 230.47 226.00 227.23 225.63 6,248,888
Jun 4, 2026 222.50 224.99 219.84 224.94 223.36 6,782,013
Jun 3, 2026 214.80 219.54 213.72 217.13 215.60 5,667,521
Jun 2, 2026 211.01 216.57 208.99 215.40 213.88 5,861,765
Jun 1, 2026 215.26 216.50 211.51 212.93 211.43 4,858,421
May 29, 2026 219.02 219.60 214.90 217.72 216.19 7,620,822
May 28, 2026 215.90 219.38 215.90 218.63 217.09 5,190,923
May 27, 2026 213.12 215.94 211.36 215.40 213.88 4,640,413
May 26, 2026 215.92 217.05 211.91 213.12 211.62 4,709,782
May 22, 2026 217.00 220.01 215.70 215.70 214.18 5,407,981
May 21, 2026 210.95 215.64 209.50 214.50 212.99 3,814,054
May 20, 2026 213.36 214.50 211.50 212.30 210.81 5,128,998
May 19, 2026 209.90 215.80 208.73 213.76 212.26 7,220,276
May 18, 2026 210.37 211.36 207.68 209.41 207.94 5,069,366
May 15, 2026 213.10 214.92 209.02 210.39 208.91 5,385,047
May 14, 2026 209.50 213.51 208.35 210.77 209.29 5,006,510
May 13, 2026 206.86 209.53 204.30 208.50 207.03 5,705,668
May 12, 2026 204.59 211.32 203.51 207.86 206.40 7,044,065
May 11, 2026 202.01 205.38 202.01 202.78 201.35 4,931,663
May 8, 2026 201.92 202.40 200.02 201.55 200.13 4,915,719
May 7, 2026 204.92 207.00 202.03 202.71 201.28 6,681,070
May 6, 2026 206.11 207.01 203.56 205.03 203.59 7,289,987
May 5, 2026 208.97 209.51 205.83 206.11 204.66 4,490,528
May 4, 2026 205.71 208.34 204.87 208.16 206.69 4,579,477
May 1, 2026 211.00 211.00 205.57 206.60 205.15 6,343,104
Apr 30, 2026 209.00 214.87 208.17 211.32 209.83 10,319,242
Apr 29, 2026 192.00 205.83 190.75 203.89 202.46 10,406,322
Apr 28, 2026 198.67 199.18 196.44 197.69 196.30 6,313,097
Apr 27, 2026 198.00 201.42 196.23 197.38 195.99 7,467,611
Apr 24, 2026 198.93 200.25 197.14 198.71 197.31 7,605,836
Apr 23, 2026 201.05 202.76 200.41 200.95 199.54 7,461,105
Apr 22, 2026 205.17 205.99 199.81 200.50 199.09 7,646,222
Apr 21, 2026 204.01 206.20 200.92 205.12 203.68 7,772,128
Apr 20, 2026 207.94 208.33 202.84 203.71 202.28 5,774,268
Apr 17, 2026 209.66 212.35 207.82 208.38 206.91 8,986,577
Apr 16, 2026 207.78 209.66 206.52 208.99 207.52 5,075,394
Apr 15, 2026$1.73 dividend 208.99 209.82 205.54 208.42 206.95 5,952,061
Apr 14, 2026 204.80 210.42 204.06 210.26 207.06 6,199,445
Apr 13, 2026 206.43 208.08 203.01 206.47 203.33 7,532,517
Apr 10, 2026 213.55 214.10 207.75 207.94 204.78 4,633,169
Apr 9, 2026 209.48 213.51 208.74 212.40 209.17 4,478,093
Apr 8, 2026 206.26 212.22 204.56 211.59 208.37 5,477,736
Apr 7, 2026 206.23 206.49 201.66 206.37 203.23 8,801,612
Apr 6, 2026 207.04 209.00 205.30 206.69 203.55 4,929,131
Apr 2, 2026 213.99 214.56 207.71 208.84 205.66 5,151,109
Apr 1, 2026 218.37 220.45 213.75 214.98 211.71 5,702,988
Mar 31, 2026 215.06 219.17 214.85 217.49 214.18 8,311,654
Mar 30, 2026 212.26 213.94 210.78 213.12 209.88 7,491,187
Mar 27, 2026 211.42 213.49 209.12 209.40 206.22 5,654,015
Mar 26, 2026 207.19 211.45 205.76 211.12 207.91 4,576,293
Mar 25, 2026 206.86 209.68 205.85 207.18 204.03 6,000,359
Mar 24, 2026 203.04 206.00 201.80 205.20 202.08 6,990,939
Mar 23, 2026 207.36 208.62 203.22 204.93 201.81 7,419,862
Mar 20, 2026 206.26 207.78 203.06 205.07 201.95 27,982,356
Mar 19, 2026 208.37 210.43 204.30 206.23 203.09 7,006,809
Mar 18, 2026 218.50 219.00 207.60 208.34 205.17 8,597,000
Mar 17, 2026 222.04 223.28 219.76 219.76 216.42 4,405,702
Mar 16, 2026 221.09 224.37 220.31 221.45 218.08 3,991,892
Mar 13, 2026 226.89 228.62 219.44 219.68 216.34 5,676,063
Mar 12, 2026 225.12 227.81 223.57 225.37 221.94 7,607,237
Mar 11, 2026 226.05 229.29 225.29 227.68 224.22 5,300,628
Mar 10, 2026 227.66 231.26 226.16 227.01 223.56 6,466,831
Mar 9, 2026 229.97 230.68 223.23 227.45 223.99 7,915,776
Mar 6, 2026 230.36 231.60 226.80 230.11 226.61 6,139,830
Mar 5, 2026 233.42 234.80 228.00 232.35 228.82 9,429,458
Mar 4, 2026 233.56 237.11 232.08 236.19 232.60 5,380,807
Mar 3, 2026 233.36 235.71 230.24 233.86 230.30 6,595,681
Mar 2, 2026 233.66 235.66 231.90 234.26 230.70 7,438,994
Feb 27, 2026 225.10 232.27 225.06 232.08 228.55 8,018,057
Feb 26, 2026 227.59 227.78 221.12 224.69 221.27 5,331,541
Feb 25, 2026 229.71 232.55 226.47 226.92 223.47 5,411,151
Feb 24, 2026 229.00 230.76 227.67 228.44 224.97 4,880,790
Feb 23, 2026 225.82 231.43 225.79 229.48 225.99 5,463,190
Feb 20, 2026 225.04 226.69 223.11 224.81 221.39 6,830,385
Feb 19, 2026 228.97 229.37 223.02 224.35 220.94 5,410,847
Feb 18, 2026 234.00 234.00 226.07 228.72 225.24 5,495,352
Feb 17, 2026 232.66 235.25 231.19 232.86 229.32 7,336,770
Feb 13, 2026 228.42 234.74 228.00 231.50 227.98 8,252,480
Feb 12, 2026 221.57 229.05 220.91 227.50 224.04 8,712,013
Feb 11, 2026 222.27 224.15 218.05 220.89 217.53 8,072,636
Feb 10, 2026 223.75 225.81 221.94 222.44 219.06 6,044,475
Feb 9, 2026 223.42 223.96 220.12 223.26 219.86 6,767,650
Feb 6, 2026 218.75 225.82 218.50 223.43 220.03 6,067,099
Feb 5, 2026 216.90 219.87 214.04 219.02 215.69 10,794,040
Feb 4, 2026 209.78 220.85 204.27 217.11 213.81 15,319,669
Feb 3, 2026 223.95 228.70 223.64 225.66 222.23 8,158,535
Feb 2, 2026 224.85 229.78 224.42 225.64 222.21 5,412,997
Jan 30, 2026 220.51 224.02 219.56 223.01 219.62 6,622,248
Jan 29, 2026 218.00 224.14 218.00 220.43 217.08 7,834,002
Jan 28, 2026 223.60 224.03 216.70 218.67 215.34 5,215,799
Jan 27, 2026 220.88 226.86 220.65 223.93 220.52 5,747,444
Jan 26, 2026 219.11 221.48 218.50 220.77 217.41 6,553,387
Jan 23, 2026 217.26 219.82 215.88 219.26 215.93 5,816,700
Jan 22, 2026 216.28 219.05 214.76 218.11 214.79 5,650,881
Jan 21, 2026 212.47 218.00 211.57 216.15 212.86 10,727,118
Jan 20, 2026 211.69 214.04 209.96 214.04 210.78 8,251,436
Jan 16, 2026$1.73 dividend 215.61 217.34 213.88 214.35 211.09 8,649,746
Jan 15, 2026 222.52 223.03 215.83 216.75 211.74 6,954,243
Jan 14, 2026 221.00 223.34 217.00 221.89 216.76 8,426,842
Jan 13, 2026 219.53 220.75 215.85 220.75 215.65 4,872,602
Jan 12, 2026 221.19 222.49 218.39 220.04 214.96 6,546,141
Jan 9, 2026 223.75 225.12 219.00 220.08 215.00 6,714,160
Jan 8, 2026 231.12 231.54 223.12 224.13 218.95 9,365,855
Jan 7, 2026 225.24 237.04 224.74 233.42 228.03 10,285,385
Jan 6, 2026 219.75 224.20 219.55 223.93 218.76 9,151,710
Jan 5, 2026 227.00 227.24 217.86 220.18 215.09 9,341,301
Jan 2, 2026 228.74 230.74 225.71 229.31 224.01 3,336,885
Dec 31, 2025 229.74 230.25 228.43 228.49 223.21 3,197,147
Dec 30, 2025 230.77 231.21 228.62 229.74 224.43 2,347,973
Dec 29, 2025 230.15 232.01 229.74 230.84 225.51 3,803,117
Dec 26, 2025 229.82 230.60 228.68 229.98 224.67 1,594,000
Dec 24, 2025 229.46 230.80 228.98 229.89 224.58 1,744,910
Dec 23, 2025 228.22 230.79 227.91 228.79 223.51 3,612,223
Dec 22, 2025 226.11 228.65 224.25 227.91 222.65 4,828,087
Dec 19, 2025 222.94 229.47 222.35 226.82 221.58 18,968,826
Dec 18, 2025 224.00 226.26 222.79 222.82 217.67 4,760,352
Dec 17, 2025 223.88 226.41 222.86 224.31 219.13 5,243,829
Dec 16, 2025 226.41 226.84 221.91 223.67 218.50 6,405,940
Dec 15, 2025 224.24 228.30 223.56 227.45 222.20 5,972,176
Dec 12, 2025 223.69 223.82 221.10 223.32 218.16 5,467,638
Dec 11, 2025 225.54 225.96 222.24 223.98 218.81 4,170,630
Dec 10, 2025 225.00 225.98 221.00 225.18 219.98 8,735,154
Dec 9, 2025 223.89 224.82 220.23 222.99 217.84 4,268,052
Dec 8, 2025 226.08 226.12 222.39 223.12 217.97 4,006,095
Dec 5, 2025 228.93 229.25 225.05 226.08 220.86 3,985,199
Dec 4, 2025 230.11 230.94 227.59 228.71 223.43 3,733,100
Dec 3, 2025 224.84 230.79 224.52 230.24 224.92 4,873,263
Dec 2, 2025 224.82 226.63 223.11 224.37 219.19 5,096,922
Dec 1, 2025 227.19 229.49 223.98 225.11 219.91 5,208,509
Nov 28, 2025 226.85 228.09 225.51 227.70 222.44 2,655,563
Nov 26, 2025 232.04 232.48 226.64 227.66 222.40 5,921,088
Nov 25, 2025 230.32 234.08 230.31 231.80 226.45 7,134,461
Nov 24, 2025 236.00 237.62 228.48 229.51 224.21 10,225,855
Nov 21, 2025 230.54 238.01 230.14 236.28 230.82 8,017,597
Nov 20, 2025 233.26 234.95 228.00 229.45 224.15 4,283,604
Nov 19, 2025 233.54 238.15 230.36 232.91 227.53 7,618,431
Nov 18, 2025 235.00 237.19 232.11 233.87 228.47 6,232,602
Nov 17, 2025 233.26 235.35 229.23 234.00 228.60 5,023,149
Nov 14, 2025 233.61 235.00 230.32 232.36 226.99 5,461,523
Nov 13, 2025 233.74 239.29 232.16 232.29 226.93 7,968,822
Nov 12, 2025 225.40 234.00 225.29 233.23 227.84 8,583,201
Nov 11, 2025 219.00 225.42 219.00 225.17 219.97 4,802,442
Nov 10, 2025 217.00 219.86 216.15 218.71 213.66 4,530,984
Nov 7, 2025 219.31 220.99 217.09 219.16 214.10 4,647,894
Nov 6, 2025 215.89 219.68 215.65 219.04 213.98 6,615,338
Nov 5, 2025 215.74 217.43 212.60 216.77 211.76 4,928,394
Nov 4, 2025 212.37 217.08 212.37 215.89 210.90 6,184,010
Nov 3, 2025 216.68 219.00 211.69 211.96 207.06 8,874,341
Oct 31, 2025 223.00 223.87 216.00 218.04 213.00 10,825,326
Oct 30, 2025 227.05 229.65 226.41 228.20 222.93 5,020,654
Oct 29, 2025 227.62 228.00 224.04 225.14 219.94 5,469,686
Oct 28, 2025 227.00 228.40 224.31 227.54 222.28 3,724,183
Oct 27, 2025 227.95 228.60 227.12 228.03 222.76 2,784,402
Oct 24, 2025 228.78 229.04 226.25 227.99 222.72 3,554,688
Oct 23, 2025 228.99 229.86 227.25 228.25 222.98 5,818,006
Oct 22, 2025 231.67 232.16 228.43 228.68 223.40 3,523,765
Oct 21, 2025 232.15 232.81 229.83 231.39 226.05 3,298,131
Oct 20, 2025 231.00 232.26 230.00 232.06 226.70 5,246,946
Oct 17, 2025 227.52 230.71 226.81 229.57 224.27 7,150,042
Oct 16, 2025 226.22 228.11 225.46 226.87 221.63 4,737,529
Oct 15, 2025$1.64 dividend 227.20 228.95 225.32 226.22 221.00 5,459,705
Oct 14, 2025 228.07 230.65 227.51 229.13 222.23 5,527,553
Oct 13, 2025 230.00 233.81 229.22 230.30 223.36 5,411,890
Oct 10, 2025 231.51 234.68 230.50 230.50 223.56 6,156,932
Oct 9, 2025 233.27 233.79 230.62 230.69 223.74 4,607,869
Oct 8, 2025 231.48 233.00 229.68 231.24 224.27 5,413,013
Oct 7, 2025 231.29 234.08 227.59 232.83 225.82 4,901,000
Oct 6, 2025 231.71 232.95 227.92 230.19 223.25 11,940,287
Oct 3, 2025 236.90 238.84 233.71 233.91 226.86 6,547,632
Oct 2, 2025 240.89 242.67 234.52 236.56 229.43 8,107,666
Oct 1, 2025 233.64 244.81 232.00 244.38 237.02 12,243,139
Sep 30, 2025 223.06 232.35 222.56 231.54 224.56 9,187,338
Sep 29, 2025 220.75 223.24 219.79 223.16 216.44 5,258,363
Sep 26, 2025 220.63 221.48 217.67 220.61 213.96 4,206,585
Sep 25, 2025 220.10 222.26 218.03 218.54 211.96 6,666,030
Sep 24, 2025 222.00 222.24 218.54 219.99 213.36 5,074,768

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
ABBVIE INC. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ABBV, per a recent SEC DEF 14A filing. We estimate that the median employee at AbbVie Inc. is paid $134,351.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation